Embryonic stem cell preconditioned microenvironment suppresses tumorigenic properties in breast cancer

[1]  X. Lou,et al.  Stat3 promotes invasion of esophageal squamous cell carcinoma through up-regulation of MMP2 , 2015, Molecular Biology Reports.

[2]  M. Zatz,et al.  Human Mesenchymal Stromal Cells Transplantation May Enhance or Inhibit 4T1 Murine Breast Adenocarcinoma through Different Approaches , 2015, Stem cells international.

[3]  H. A. Rogoff,et al.  Suppression of cancer relapse and metastasis by inhibiting cancer stemness , 2015, Proceedings of the National Academy of Sciences.

[4]  Sheng-yong Yang,et al.  Overexpression of Oct4 suppresses the metastatic potential of breast cancer cells via Rnd1 downregulation. , 2014, Biochimica et biophysica acta.

[5]  Hua Yu,et al.  Revisiting STAT3 signalling in cancer: new and unexpected biological functions , 2014, Nature Reviews Cancer.

[6]  S. Hilsenbeck,et al.  STAT3 Signaling Is Activated Preferentially in Tumor‐Initiating Cells in Claudin‐Low Models of Human Breast Cancer , 2014, Stem cells.

[7]  Weijun Su,et al.  Molecular imaging for assessment of mesenchymal stem cells mediated breast cancer therapy. , 2014, Biomaterials.

[8]  A. Zoubeidi,et al.  The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer , 2014, Cancers.

[9]  A. Bishayee,et al.  Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors. , 2014, Biochimica et biophysica acta.

[10]  Hua Yu,et al.  Loss of androgen receptor expression promotes a stem-like cell phenotype in prostate cancer through STAT3 signaling. , 2014, Cancer research.

[11]  Zongjin Li,et al.  Nanoparticle-based tumor theranostics with molecular imaging. , 2014, Current pharmaceutical biotechnology.

[12]  Weijun Su,et al.  Human Embryonic Stem Cell-Derived Endothelial Cells as Cellular Delivery Vehicles for Treatment of Metastatic Breast Cancer , 2013, Cell transplantation.

[13]  N. Maitland,et al.  JAK-STAT blockade inhibits tumor initiation and clonogenic recovery of prostate cancer stem-like cells. , 2013, Cancer research.

[14]  L. Pfeffer,et al.  Constitutive Activation of Signal Transducer and Activator of Transcription 3 (STAT3) and Nuclear Factor κB Signaling in Glioblastoma Cancer Stem Cells Regulates the Notch Pathway* , 2013, The Journal of Biological Chemistry.

[15]  R. Xiang,et al.  Tumor‐Associated Macrophages Regulate Murine Breast Cancer Stem Cells Through a Novel Paracrine EGFR/Stat3/Sox‐2 Signaling Pathway , 2013, Stem cells.

[16]  Massimo Broggini,et al.  Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact. , 2012, Cancer treatment reviews.

[17]  Weijun Su,et al.  Assessment of therapeutic efficacy of liposomal nanoparticles mediated gene delivery by molecular imaging for cancer therapy. , 2012, Journal of biomedical nanotechnology.

[18]  Weijun Su,et al.  CD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma. , 2012, Biomaterials.

[19]  D. Mankoff,et al.  Advances in molecular imaging for breast cancer detection and characterization , 2012, Breast Cancer Research.

[20]  I. Ng,et al.  CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation. , 2011, Cell stem cell.

[21]  Mithat Gönen,et al.  The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors. , 2011, The Journal of clinical investigation.

[22]  Yubing Xie,et al.  Bioengineering embryonic stem cell microenvironments for exploring inhibitory effects on metastatic breast cancer cells. , 2011, Biomaterials.

[23]  Jane E. Visvader,et al.  Cells of origin in cancer , 2011, Nature.

[24]  H. Ford,et al.  Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression , 2010, Journal of Mammary Gland Biology and Neoplasia.

[25]  M. Karin,et al.  Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. , 2010, Cancer cell.

[26]  Hua Yu,et al.  STATs in cancer inflammation and immunity: a leading role for STAT3 , 2009, Nature Reviews Cancer.

[27]  Eric S. Lander,et al.  Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening , 2009, Cell.

[28]  Jeffrey M. Rosen,et al.  The Increasing Complexity of the Cancer Stem Cell Paradigm , 2009, Science.

[29]  G. D'aiuto,et al.  Metabolic syndrome, hyperinsulinaemia and body mass index as risk factors in breast cancer: National Cancer Institute of Naples experience , 2009, Breast Cancer Research.

[30]  Xiao-Jun Ma,et al.  Gene expression profiling of the tumor microenvironment during breast cancer progression , 2009, Breast Cancer Research.

[31]  Mina J Bissell,et al.  Unraveling the microenvironmental influences on the normal mammary gland and breast cancer. , 2008, Seminars in cancer biology.

[32]  J. Visvader,et al.  Cancer stem cells in solid tumours: accumulating evidence and unresolved questions , 2008, Nature Reviews Cancer.

[33]  M. Mourtada-Maarabouni,et al.  Investigation of the roles of novel apoptosis-controlling genes in breast cancer , 2008, Breast Cancer Research.

[34]  S. Gambhir,et al.  Noninvasive molecular imaging of small living subjects using Raman spectroscopy , 2008, Proceedings of the National Academy of Sciences.

[35]  D. Frank Targeting transcription factors for cancer therapy. , 2008, IDrugs : the investigational drugs journal.

[36]  Charlotte Kuperwasser,et al.  Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy , 2008, Breast Cancer Research.

[37]  M. Hendrix,et al.  Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells , 2008, Proceedings of the National Academy of Sciences.

[38]  Ying-Xuan Chen,et al.  Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells. , 2008, Neoplasia.

[39]  Zhong Chen,et al.  STAT3: A critical transcription activator in angiogenesis , 2008, Medicinal research reviews.

[40]  M. Hendrix,et al.  The Epigenetic Influence of Tumor and Embryonic Microenvironments: How Different are They? , 2008, Cancer Microenvironment.

[41]  M. Blagosklonny Cancer stem cell and cancer stemloids: From biology to therapy , 2007, Cancer biology & therapy.

[42]  Erik Sahai,et al.  Illuminating the metastatic process , 2007, Nature Reviews Cancer.

[43]  Michael F. Clarke,et al.  Phenotypic characterization of human colorectal cancer stem cells , 2007, Proceedings of the National Academy of Sciences.

[44]  Mary J. C. Hendrix,et al.  Reprogramming metastatic tumour cells with embryonic microenvironments , 2007, Nature Reviews Cancer.

[45]  J. Dick,et al.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.

[46]  R. Weissleder Molecular Imaging in Cancer , 2006, Science.

[47]  K. Aldape,et al.  Activation of stat3 in human melanoma promotes brain metastasis. , 2006, Cancer research.

[48]  M. Hendrix,et al.  A Three‐Dimensional Model to Study the Epigenetic Effects Induced by the Microenvironment of Human Embryonic Stem Cells , 2006, Stem cells.

[49]  P. Dalerba,et al.  Identification of pancreatic cancer stem cells. , 2006, Cancer research.

[50]  Thomas Kirchner,et al.  Migrating cancer stem cells — an integrated concept of malignant tumour progression , 2005, Nature Reviews Cancer.

[51]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[52]  G. Dontu,et al.  In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. , 2003, Genes & development.

[53]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[54]  J. Darnell Transcription factors as targets for cancer therapy , 2002, Nature Reviews Cancer.

[55]  J. Turkson,et al.  STAT proteins: novel molecular targets for cancer drug discovery , 2000, Oncogene.

[56]  J. Darnell,et al.  The role of STATs in transcriptional control and their impact on cellular function , 2000, Oncogene.

[57]  J. Darnell,et al.  Stat3 as an Oncogene , 1999, Cell.

[58]  A. Smith,et al.  Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. , 1998, Genes & development.

[59]  M. Kaufman,et al.  Establishment in culture of pluripotential cells from mouse embryos , 1981, Nature.

[60]  J. Uhm,et al.  The transcriptional network for mesenchymal transformation of brain tumours , 2010 .

[61]  Mina J Bissell,et al.  Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? , 2005, Cancer cell.

[62]  John E. Shelton People's Republic of China , 1973 .